Injectable Drug Delivery Resources
-
New Technologies To Improve Solubility Of Brick Dust Compounds
7/13/2022
David Lyon, Ph.D., and Molly Adam answer attendee questions from a recent webinar about three enabling technologies designed to improve drug solubility in organic solvents for spray drying.
-
De-Risking FDA Abbreviated New Drug Application (ANDA) Submissions
6/26/2025
Discover an autoinjector platform that supports ANDA pathways with demonstrated usability and design alignment to help development teams reduce risk and move confidently toward regulatory submission.
-
Fixtures And Surrogates For Combination Product Performance Testing
5/16/2025
The combination product market is consistently expanding. Transitioning from traditional vial systems to needle-based combination products presents several challenges that require careful consideration.
-
Improved Biomanufacturing Processes And Drug Product Stability
9/20/2022
Improve upstream media for bioavailability and foam stability, downstream buffers for purification, and the formulation and final fill drug product stability with this highly interdisciplinary process.
-
Understanding Risks Of Biologic Drugs And Injectable Drug-Device Combination Products
As the benefits of delivering biologic drugs as part of a combination product platform are realized, this self-administration trend will continue to grow. From a regulatory perspective, the use of a risk-based approach is foundational.
-
Is Your Combination Product Drug-Led Or Device-Led?
11/30/2022
The $118 billion combination-product market is projected to increase at a CAGR of 8.8%. This article answers the question: “Is this actually a combination product? What do we need to do if it is?”
-
Wet Milling Vs. Dry Milling In The Pharmaceutical Industry
8/10/2022
Read about the considerations necessary for choosing between wet milling and dry milling for a specific active pharmaceutical ingredient.
-
Vial Containment Systems Based On Elastomer 4031/45 Gray
10/1/2024
Examine the results of two, two-year studies that indicate good container closure integrity performance that can be achieved with stoppers of a given elastomer, independent of configuration.
-
Evaluating A Novel Cyclic Olefin Polymer Container System For Storing AAV
7/20/2023
This study investigates the suitability of a container system composed of the novel COP CZ as an alternative for the ultra-cold storage of therapeutically relevant AAV viral vectors.
-
The Path To Commercialization For Wearable Drug Delivery Devices
Explore the evolution of the wearable drug delivery market, including the route to commercialization and the challenges faced.